19 hours ago
1
vzphotos/iStock Editorial via Getty Images
- AbbVie (NYSE:ABBV) is reportedly in talks to acquire privately held mental health drug developer Gilgamesh Pharmaceuticals in a deal valued at around $1 billion, according to Bloomberg News, citing sources familiar with the matter.
- The potential deal comes as AbbVie
English (US) ·